SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-16-098169
Filing Date
2016-02-12
Accepted
2016-02-12 17:19:18
Documents
1
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 5 SUBMISSION doc5.html 5  
1 FORM 5 SUBMISSION doc5.xml 5 3539
  Complete submission text file 0001209191-16-098169.txt   5077
Mailing Address 615 ARAPEEN DRIVE SUITE 102 SALT LAKE CITY UT 84108
Business Address 615 ARAPEEN DRIVE SUITE 102 SALT LAKE CITY UT 84108 (801) 582-5400
Q Therapeutics, Inc. (Issuer) CIK: 0001366541 (see all company filings)

IRS No.: 203708500 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address PO BOX 58154 SALT LAKE CITY UT 84158
Business Address
BORST STEVEN JOHN (Reporting) CIK: 0001532620 (see all company filings)

Type: 5 | Act: 34 | File No.: 000-52062 | Film No.: 161420787